Year archive

Knight Therapeutics Inc. — 2022 filings

All 27 regulatory filings released by Knight Therapeutics Inc. (GUD) in 2022, sourced directly from the official regulator.

27 Filings

2022 Period

2022 filings (27)

Filing	Released	Lang
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2022-11-10	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2022-11-10	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2022-11-10	English
Interim MD&A - English.pdf Interim / Quarterly Report	2022-11-10	English
News release - English.pdf Interim / Quarterly Report	2022-11-10	English
News release - French.pdf Interim / Quarterly Report	2022-11-10	English
52-109F2 - Certification of interim filings - CFO (E).pdf Interim / Quarterly Report	2022-08-11	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2022-08-11	English
Interim MD&A - English.pdf Interim / Quarterly Report	2022-08-11	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2022-08-11	English
News release - English.pdf Interim / Quarterly Report	2022-08-11	English
News release - French.pdf Interim / Quarterly Report	2022-08-11	English
News release - French.pdf Transaction in Own Shares	2022-07-12	English
News release - English.pdf Transaction in Own Shares	2022-07-12	English
Annual report - English.pdf Annual Report	2022-03-30	English
Annual report - French.pdf Annual Report	2022-03-30	English
News release - French.pdf Annual Report	2022-03-24	English
Annual information form - English.pdf Regulatory Filings	2022-03-24	English
52-109F1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2022-03-24	English
52-109F1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2022-03-24	English
Annual MD&A - English.pdf Regulatory Filings	2022-03-24	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2022-03-24	English
Audited annual financial statements – English.pdf Annual Report	2022-03-24	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2022-03-24	English
News release - English.pdf Interim / Quarterly Report	2022-03-24	English
Notice of the meeting and record date - French.pdf AGM Information	2022-02-25	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2022-02-25	English